Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based StudyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|American Journal of Respiratory and Critical Care Medicine|2023Cited by 79
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control studyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|BMC Pulmonary Medicine|2024Cited by 3
The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populationsAnne E Ioannides, Jennifer K. Quint, Hana Mullerova et al.|BMC Medicine|2026Cited by 1
Adverse Events Following Major Adverse Cardiovascular Events(MACE) in People With COPD: An Analysis of Exacerbations, MACE and MortalityAnne E Ioannides, Jennifer K Quint, Emily L. Graul|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0
The Relationship Between Four Elements of COPD and Major Adverse Cardiovascular Events(MACE) Amongst People at Elevated Risk of MACEAnne E Ioannides, Jennifer K Quint, Emily L. Graul et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0